Prot# APD371-202: A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Evaluate the Safety, Tolerability, and Efficacy of Olorinab in Subjects with Irritable Bowel Syndrome Experiencing Abdominal Pain

Project: Research project

Project Details

StatusFinished
Effective start/end date5/8/20 → 5/8/23

Funding

  • DrugDev Inc. (Prot# APD371-202 // Prot# APD371-202)
  • Arena Pharmaceuticals, Inc. (Prot# APD371-202 // Prot# APD371-202)